As of mid-August 2026, the CDC has confirmed over 2,566 measles cases nationwide, with 94% outbreak-associated and recent two-week totals exceeding 230 infections, driven primarily by sustained transmission in under-vaccinated communities following imported introductions. This pace far exceeds 2025’s full-year total of 2,289 and reflects high contagiousness (R0 of 12–18) among susceptible populations lacking MMR immunity. Weekly CDC surveillance updates through late August, alongside state health department reports, will determine final counts by the August 31 resolution date; continued weekly additions of 50–100 cases remain possible absent abrupt containment shifts. Trader sentiment reflects these verified epidemiological trends and the narrow remaining window for new data.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया31 अगस्त तक अमेरिका में खसरे के मामले?
31 अगस्त तक अमेरिका में खसरे के मामले?
$18,617 वॉल्यूम
31 अग, 2026
2750+
74%
2600+
99%
2650+
96%
2700+
91%
$18,617 वॉल्यूम
2750+
$2,229 वॉल्यूम
74%
2600+
$3,985 वॉल्यूम
99%
2650+
$1,818 वॉल्यूम
96%
2700+
$1,134 वॉल्यूम
91%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has confirmed over 2,566 measles cases nationwide, with 94% outbreak-associated and recent two-week totals exceeding 230 infections, driven primarily by sustained transmission in under-vaccinated communities following imported introductions. This pace far exceeds 2025’s full-year total of 2,289 and reflects high contagiousness (R0 of 12–18) among susceptible populations lacking MMR immunity. Weekly CDC surveillance updates through late August, alongside state health department reports, will determine final counts by the August 31 resolution date; continued weekly additions of 50–100 cases remain possible absent abrupt containment shifts. Trader sentiment reflects these verified epidemiological trends and the narrow remaining window for new data.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
बाज़ार खुला: Jul 31, 2026, 12:30 PM ET
वॉल्यूम
$18,617समाप्ति तिथि
31 अग, 2026बाज़ार खुला
Jul 31, 2026, 12:30 PM ETResolver
0x65070BE91...परिणाम प्रस्तावित: हाँ
कोई विवाद नहीं
अंतिम परिणाम: हाँ
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, the CDC has confirmed over 2,566 measles cases nationwide, with 94% outbreak-associated and recent two-week totals exceeding 230 infections, driven primarily by sustained transmission in under-vaccinated communities following imported introductions. This pace far exceeds 2025’s full-year total of 2,289 and reflects high contagiousness (R0 of 12–18) among susceptible populations lacking MMR immunity. Weekly CDC surveillance updates through late August, alongside state health department reports, will determine final counts by the August 31 resolution date; continued weekly additions of 50–100 cases remain possible absent abrupt containment shifts. Trader sentiment reflects these verified epidemiological trends and the narrow remaining window for new data.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
वॉल्यूम
$18,617समाप्ति तिथि
31 अग, 2026बाज़ार खुला
Jul 31, 2026, 12:30 PM ETResolver
0x65070BE91...परिणाम प्रस्तावित: हाँ
कोई विवाद नहीं
अंतिम परिणाम: हाँ
As of mid-August 2026, the CDC has confirmed over 2,566 measles cases nationwide, with 94% outbreak-associated and recent two-week totals exceeding 230 infections, driven primarily by sustained transmission in under-vaccinated communities following imported introductions. This pace far exceeds 2025’s full-year total of 2,289 and reflects high contagiousness (R0 of 12–18) among susceptible populations lacking MMR immunity. Weekly CDC surveillance updates through late August, alongside state health department reports, will determine final counts by the August 31 resolution date; continued weekly additions of 50–100 cases remain possible absent abrupt containment shifts. Trader sentiment reflects these verified epidemiological trends and the narrow remaining window for new data.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया
बाहरी लिंक से सावधान रहें।
बाहरी लिंक से सावधान रहें।
अक्सर पूछे जाने वाले प्रश्न